Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Perrigo Co plc

NYSE: PRGO · Life Sciences · 2 alerts · CIK 1585364

Share price
$16.18Close, Nov 16
Market cap
$2.25B
Shares outstanding
138.8MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Perrigo Co plc filings on SEC EDGAR ↗

6:45 AM ET 8-K
Financial Results

Perrigo Co Financial Results

Perrigo reported third quarter 2026 financial results, showing a 5.2% decline in 'All In' net sales to $989 million and a reported diluted loss per share of $0.10. The company updated its full-year outlook to reflect the divestiture of its Infant Formula business and more cautious retailer inventory positioning ahead of the cough and cold season.

Term
Q3 2026

“Our Three-S plan is delivering continued progress in the areas of the business within our control. We gained market share again in U.S. store brand OTC and in key European brands. Category trends improved sequentially, which, combined with disciplined cost management, helped offset a difficult consumer backdrop.”

Albert Manzone, Interim President and Chief Executive Officer

“The sale of Infant Formula is an important step in evolving Perrigo into a more focused consumer self-care company. It is expected to enhance our margin profile, materially reduce expected future capital expenditures, and support continued deleveraging and reinvestment in the business. The result will be a simpler Perrigo, better positioned for profitable growth.”

Albert Manzone, Interim President and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.